PDR: A New Anti-VEGF Era?
Available from: 11/12/2018
Where to publish: www.mivision.com.au and mieducation.com
Contact: Nikki Byrne, [E] email@example.com, [P] 02 8336 8616
- How to diagnose proliferative diabetic retinopathy
- The prevalence and epidemiology of proliferative diabetic retinopathy
- The risk factors for proliferative diabetic retinopathy
- The clinical features of proliferative diabetic retinopathy and that this is an eye-threatening disease
- Ocular and systemic investigations required for proliferative diabetic retinopathy. Ocular investigations to be discussed include: optical coherence tomography, fluorescein angiography and OCT-angiography.
- That both ocular and systemic management is required for the treatment of proliferative diabetic retinopathy. That the mainstay of ocular management is panretinal photocoagulation, although intra-vitreal anti-VEGF therapy may also have a role.
- The indications for performing vitrectomy surgery in patients with proliferative diabetic retinopathy
Max points awarded: 2.00
|PDR: A New Anti-VEGF Era?|
|Independent Learning with Assessment|
|Points for attending & Passing Assessment|
|Points for attending &|
|PDR: A New Anti-VEGF Era?||Independent Learning with Assessment||No||No||2.00|